Latest Breaking News On - Cartesian therapeutics inc - Page 5 : comparemela.com

Cartesian Therapeutics (NASDAQ:RNAC) Price Target Raised to $54.00

Cartesian Therapeutics (NASDAQ:RNAC – Free Report) had its price target upped by HC Wainwright from $2.00 to $54.00 in a research report released on Tuesday, Marketbeat Ratings reports. They currently have a buy rating on the stock. HC Wainwright also issued estimates for Cartesian Therapeutics’ Q1 2024 earnings at ($0.27) EPS, Q2 2024 earnings at […]

Hall laurieTimothya springerSecurities exchange commissionNeedham companyCartesian therapeutics incCartesian therapeutics company profileCartesian therapeuticsFree reportMarketbeat ratingsGet free reportDirector timothyExchange commissionLauriej trusteeCartesian therapeutics dailyNasdaq rnacBoost price target

Cartesian Therapeutics (NASDAQ:RNAC) Rating Reiterated by Leerink Partnrs

Leerink Partnrs reissued their outperform rating on shares of Cartesian Therapeutics (NASDAQ:RNAC – Free Report) in a research note issued to investors on Tuesday, Zacks.com reports. Leerink Partnrs also issued estimates for Cartesian Therapeutics’ Q1 2024 earnings at ($1.34) EPS, Q2 2024 earnings at ($1.38) EPS, Q3 2024 earnings at ($1.27) EPS, Q4 2024 earnings […]

Leerink partnrsHall laurieTimothya springerCartesian therapeutics incNeedham companyCartesian therapeuticsFree reportGet free reportDirector timothyLauriej trusteeCartesian therapeutics dailyNasdaq rnacReiterated rating

Cartesian Therapeutics, Inc. (NASDAQ:RNAC) to Post Q1 2024 Earnings of ($0.27) Per Share, HC Wainwright Forecasts

Cartesian Therapeutics, Inc. (NASDAQ:RNAC) to Post Q1 2024 Earnings of ($0.27) Per Share, HC Wainwright Forecasts
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Timothya springerHall laurieLeerink partnrsCartesian therapeutics company profileNeedham companyCartesian therapeutics incCartesian therapeuticsFree reportCartesian therapeuticGet free reportLauriej trusteeDirector timothyCartesian therapeutics daily

Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday's Mid-Day Session - Abeona Therapeutics (NASDAQ:ABEO), Anitra (AMEX:AZTR)

United statesJohn deereCarmell corporationSasol limitedInternational incBiosystems incAbeona therapeutics incSolaria incSimpson manufacturing co incBloom energy corporationGreenwave technology solutionsCapital oneFuelcell energy incF incHealthstream incCanaan inc

Cartesian Therapeutics to Present at the ASGCT 27th Annual Meeting

Cartesian Therapeutics, Inc. , a clinical-stage biotechnology company pioneering mRNA cell therapy for autoimmune diseases, today announced that recently reported twelve-month follow-up data from.

United statesCompany on linkedinCartesian therapeutics incAmerican society of geneCartesian therapeuticsAmerican societyCell therapyAnnual meetingAutoimmune diseaseMyasthenia gravisCell based gene therapy trialsFriday may